136 related articles for article (PubMed ID: 9726381)
1. Increased bone resorption in patients with Crohn's disease.
Robinson RJ; Iqbal SJ; Abrams K; Al-Azzawi F; Mayberry JF
Aliment Pharmacol Ther; 1998 Aug; 12(8):699-705. PubMed ID: 9726381
[TBL] [Abstract][Full Text] [Related]
2. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
[TBL] [Abstract][Full Text] [Related]
3. Abnormal bone turnover in long-standing Crohn's disease in remission.
Schoon EJ; Geerling BG; Van Dooren IM; Schurgers LJ; Vermeer C; Brummer RJ; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Jun; 15(6):783-92. PubMed ID: 11380316
[TBL] [Abstract][Full Text] [Related]
4. Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease.
Tuchman S; Thayu M; Shults J; Zemel BS; Burnham JM; Leonard MB
J Pediatr; 2008 Oct; 153(4):484-90. PubMed ID: 18555484
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone status and bone metabolism in men with Crohn's disease.
Robinson RJ; Iqbal SJ; Al-Azzawi F; Abrams K; Mayberry JF
Aliment Pharmacol Ther; 1998 Jan; 12(1):21-5. PubMed ID: 9692696
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone density in patients with inflammatory bowel disease.
Bjarnason I; Macpherson A; Mackintosh C; Buxton-Thomas M; Forgacs I; Moniz C
Gut; 1997 Feb; 40(2):228-33. PubMed ID: 9071937
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
8. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?
Schoon EJ; Müller MC; Vermeer C; Schurgers LJ; Brummer RJ; Stockbrügger RW
Gut; 2001 Apr; 48(4):473-7. PubMed ID: 11247890
[TBL] [Abstract][Full Text] [Related]
9. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
10. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
Klaus J; Reinshagen M; Adler G; Boehm B; von Tirpitz C
BMC Gastroenterol; 2008 Oct; 8():48. PubMed ID: 18947388
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis and determinants of bone density in patients with Crohn's disease.
Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF
Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142
[TBL] [Abstract][Full Text] [Related]
12. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
13. Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.
von Tirpitz C; Epp S; Klaus J; Mason R; Hawa G; Brinskelle-Schmal N; Hofbauer LC; Adler G; Kratzer W; Reinshagen M
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1165-70. PubMed ID: 14560148
[TBL] [Abstract][Full Text] [Related]
14. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
15. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
16. The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease.
Robinson RJ; al-Azzawi F; Iqbal SJ; Abrams K; Mayberry JF
Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):945-9. PubMed ID: 9391782
[TBL] [Abstract][Full Text] [Related]
17. Relationship of bone turnover to bone density and fractures.
Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis.
Yilmaz N; Bayram M; Erbåğci AB; Kilinçer MS
Clin Chem Lab Med; 1999 Feb; 37(2):137-43. PubMed ID: 10219502
[TBL] [Abstract][Full Text] [Related]
19. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced bone turnover markers and low bone mineral density in patients with osteonecrosis of the femoral head.
Tian L; Baek SH; Jang J; Kim SY
Int Orthop; 2018 Jul; 42(7):1545-1549. PubMed ID: 29589087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
